Cloning, expression and characterization of ferret CXCL10

Molecular Immunology

Volumn 45, Issue 5, 2008, Pages 1288-1297

  Danesh, Ali ^a,b   Seneviratne, Charit ^a   Cameron, Cheryl M ^a   Banner, David ^a   Devries, Mark E ^a   Kelvin, Alyson A ^a   Xu, Luoling ^a   Ran, Longsi ^a   Bosinger, Steven E ^a   Rowe, Thomas ^c   Czub, Marcus ^d   Jonsson, Colleen B ^c   Cameron, Mark J ^a   Kelvin, David J ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d Public Health Agency of Canada   (Canada)

Author keywords

Animal model; Chemokines; CXCL10; CXCL11; CXCL9; CXCR3; Ferret; SARS

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FERRET; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INFECTION;

ANIMALS; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; CLONING, MOLECULAR; FERRETS; GENE EXPRESSION REGULATION; MALE; MODELS, ANIMAL; RECEPTORS, CXCR3; SEVERE ACUTE RESPIRATORY SYNDROME;

ANIMALIA; MUSTELA; SARS CORONAVIRUS;

EID: 37349000544     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.09.018     Document Type: Article

References (41)

1. Cameron, M.J., Bermejo-Martin, J.F., Danesh, A., Muller, M.P., Kelvin, D.J., 2007a. Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Res. [Epub ahead of print].
2. Cameron M.J., and Kelvin D.J. Cytokines and chemokines-their receptors and their genes: an overview. Adv. Exp. Med. Biol. 520 (2003) 8-32
3. Cameron M.J., Ran L., Xu L., Danesh A., Bermejo-Martin J.F., Cameron C.M., Muller M.P., Gold W.L., Richardson S.E., Poutanen S.M., Willey B.M., Devries M.E., Fang Y., Seneviratne C., Bosinger S.E., Persad D., Wilkinson P., Greller L.D., Somogyi R., Humar A., Keshavjee S., Louie M., Loeb M.B., Brunton J., McGeer A.J., and Kelvin D.J. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in severe acute respiratory syndrome (SARS) patients. J. Virol. 81 16 (2007) 8692-8706
4. Carr D.J., Chodosh J., Ash J., and Lane T.E. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J. Virol. 77 (2003) 10037-10046
5. Cheung C.Y., Poon L.L., Ng I.H., Luk W., Sia S.F., Wu M.H., Chan K.H., Yuen K.Y., Gordon S., Guan Y., and Peiris J.S. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 79 (2005) 7819-7826
6. Chien J.Y., Hsueh P.R., Cheng W.C., Yu C.J., and Yang P.C. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology 11 (2006) 715-722
7. Christen U., Benke D., Wolfe T., Rodrigo E., Rhode A., Hughes A.C., Oldstone M.B., and von Herrath M.G. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 113 (2004) 74-84
8. Christensen J.E., de Lemos C., Moos T., Christensen J.P., and Thomsen A.R. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J. Immunol. 176 (2006) 4235-4243
9. Dawson T.C., Beck M.A., Kuziel W.A., Henderson F., and Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156 (2000) 1951-1959
10. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., and Luster A.D. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168 (2002) 3195-3204
11. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61 (1997) 246-257
12. Glass W.G., Subbarao K., Murphy B., and Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 173 (2004) 4030-4039
13. Govorkova E.A., Rehg J.E., Krauss S., Yen H.L., Guan Y., Peiris M., Nguyen T.D., Hanh T.H., Puthavathana P., Long H.T., Buranathai C., Lim W., Webster R.G., and Hoffmann E. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 79 (2005) 2191-2198
14. Krathwohl M.D., and Anderson J.L. Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model. Vaccine 24 (2006) 2987-2993
15. Liao F., Rabin R.L., Yannelli J.R., Koniaris L.G., Vanguri P., and Farber J.M. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182 (1995) 1301-1314
16. Liu M.T., Keirstead H.S., and Lane T.E. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J. Immunol. 167 (2001) 4091-4097
17. Loos T., Dekeyzer L., Struyf S., Schutyser E., Gijsbers K., Gouwy M., Fraeyman A., Put W., Ronsse I., Grillet B., Opdenakker G., Van Damme J., and Proost P. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis. Lab. Invest. 86 (2006) 902-916
18. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
19. Maines T.R., Lu X.H., Erb S.M., Edwards L., Guarner J., Greer P.W., Nguyen D.C., Szretter K.J., Chen L.M., Thawatsupha P., Chittaganpitch M., Waicharoen S., Nguyen D.T., Nguyen T., Nguyen H.H., Kim J.H., Hoang L.T., Kang C., Phuong L.S., Lim W., Zaki S., Donis R.O., Cox N.J., Katz J.M., and Tumpey T.M. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79 (2005) 11788-11800
20. Marshall E., and Enserink M. Medicine. Caution urged on SARS vaccines. Science 303 (2004) 944-946
21. Martina B.E., Haagmans B.L., Kuiken T., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., Peiris J.S., Lim W., and Osterhaus A.D. Virology: SARS virus infection of cats and ferrets. Nature 425 (2003) 915
22. Nau G.J., Schlesinger A., Richmond J.F., and Young R.A. Cumulative toll-like receptor activation in human macrophages treated with whole bacteria. J. Immunol. 170 (2003) 5203-5209
23. Ng P.C., Lam C.W., Li A.M., Wong C.K., Leung T.F., Cheng F.W., Hon K.L., Chan I.H., Wong E., and Fok T.F. Chemokine response in children with SARS. Arch. Dis. Child. 90 (2005) 422-423
24. Ng W.F., To K.F., Lam W.W., Ng T.K., and Lee K.C. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1-a review. Hum. Pathol. 37 (2006) 381-390
25. Peiris J.S., Yu W.C., Leung C.W., Cheung C.Y., Ng W.F., Nicholls J.M., Ng T.K., Chan K.H., Lai S.T., Lim W.L., Yuen K.Y., and Guan Y. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363 (2004) 617-619
26. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., and Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101 (1998) 746-754
27. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
28. Ruth J.H., Rottman J.B., Katschke Jr. K.J., Qin S., Wu L., LaRosa G., Ponath P., Pope R.M., and Koch A.E. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum. 44 (2001) 2750-2760
29. Shigihara T., Shimada A., Oikawa Y., Yoneyama H., Kanazawa Y., Okubo Y., Matsushima K., Yamato E., Miyazaki J., Kasuga A., Saruta T., and Narumi S. CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice. J. Immunol. 175 (2005) 8401-8408
30. Sidwell R.W., and Smee D.F. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res. 48 (2000) 1-16
31. Sorensen T.L., and Ransohoff R.M. Etiology and pathogenesis of multiple sclerosis. Semin. Neurol. 18 (1998) 287-294
32. Suguitan Jr. A.L., McAuliffe J., Mills K.L., Jin H., Duke G., Lu B., Luke C.J., Murphy B., Swayne D.E., Kemble G., and Subbarao K. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med. 3 (2006) e360
33. Sweet C., and Smith H. Pathogencity of influenza viruses. Microbiol. Rev. 44 (1980) 303-330
34. Tang N.L., Chan P.K., Wong C.K., To K.F., Wu A.K., Sung Y.M., Hui D.S., Sung J.J., and Lam C.W. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin. Chem. 51 (2005) 2333-2340
35. Tassiulas I., Park-Min K.H., Hu Y., Kellerman L., Mevorach D., and Ivashkiv L.B. Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum. Immunol. 68 (2007) 156-164
36. Tschen S.I., Stohlman S.A., Ramakrishna C., Hinton D.R., Atkinson R.D., and Bergmann C.C. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur. J. Immunol. 36 (2006) 603-612
37. Vos A., Muller T., Cox J., Neubert L., and Fooks A.R. Susceptibility of ferrets (Mustela putorius furo) to experimentally induced rabies with European Bat Lyssaviruses (EBLV). J. Vet. Med. B: Infect. Dis. Vet. Public Health 51 (2004) 55-60
38. Xie J.H., Nomura N., Lu M., Chen S.L., Koch G.E., Weng Y., Rosa R., Di Salvo J., Mudgett J., Peterson L.B., Wicker L.S., and DeMartino J.A. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J. Leukoc. Biol. 73 (2003) 771-780
39. Xu L., Kelvin D.J., Ye G.Q., Taub D.D., Ben Baruch A., Oppenheim J.J., and Wang J.M. Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL-8. J. Leukoc. Biol. 57 (1995) 335-342
40. Ye J., Zhang B., Xu J., Chang Q., McNutt M.A., Korteweg C., Gong E., and Gu J. Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am. J. Pathol. 170 (2007) 538-545
41. Zitzow L.A., Rowe T., Morken T., Shieh W.J., Zaki S., and Katz J.M. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol. 76 (2002) 4420-4429